Health Economics and Outcomes Research (HEOR) Strategy Plans and Gap Analyses for a Treatment Targeting Multiple Rare Diseases
Preparing for launch in multiple countries with a comprehensive evidence strategy
Observational Study of Patient-Reported Quality of Life Utilizing a Novel Mobile Application
Using a mobile app to understand the experience of advanced or metastatic breast cancer patients undergoing a specific treatment
PRO Analysis Portfolio Across Multiple Cancers
Maximizing the usefulness of patient-reported HRQOL data collected across multiple cancer trials
Multinational Observational Study in Chronic Idiopathic Urticaria
Supporting development and commercialization strategy with burden of illness data
Cross-Sectional Survey of Pneumococcal Vaccine Prescribers
Understanding healthcare provider attitudes ahead of Advisory Committee on Immunization Practices (ACIP) recommendations
Pooled Data Analysis of Long-Term Treatment Effect
Demonstrating the benefit of a treatment in slowing kidney function decline
HRQOL Data Analysis Pooled Across Multiple Trials
Demonstrating health-related quality of life benefit of an oncology product
Cross-Sectional Surveys to Assess Knowledge of Vaccines Among HCPs and Consumers
Measuring distinct concepts across therapeutic areas while understanding the respective evolving vaccine guidelines
Integrated Real-World Clinical and Economic Evaluation of Treatment Alternatives
Supporting the value of a disease-modifying therapy in multiple sclerosis
Decision-Analytic Model to Estimate Costs and Outcomes for Additional Screening for Ischemic Stroke Treatment
Understanding the cost-effectiveness of CTP or MRI screening to select patients for IV tPA treatment